In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
Ed Snyder of Charter Equity Research reacts to Intel's latest set of earnings, saying government help will not be enough to help turn the company's fortunes around.
Some results have been hidden because they may be inaccessible to you